These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 36601912)
1. A rare and fatal cause of hypertrophic cardiomyopathy: Danon disease. Türkmen H; Uysal F; Bostan ÖM Cardiol Young; 2023 Aug; 33(8):1448-1450. PubMed ID: 36601912 [TBL] [Abstract][Full Text] [Related]
2. Early onset of cardiomyopathy and intellectual disability in a girl with Danon disease associated with a de novo novel mutation of the LAMP2 gene. Sugie K; Yoshizawa H; Onoue K; Nakanishi Y; Eura N; Ogawa M; Nakano T; Sakaguchi Y; Hayashi YK; Kishimoto T; Shima M; Saito Y; Nishino I; Ueno S Neuropathology; 2016 Dec; 36(6):561-565. PubMed ID: 27145725 [TBL] [Abstract][Full Text] [Related]
4. Identification of LAMP2 Mutations in Early-Onset Danon Disease With Hypertrophic Cardiomyopathy by Targeted Next-Generation Sequencing. Fu L; Luo S; Cai S; Hong W; Guo Y; Wu J; Liu T; Zhao C; Li F; Huang H; Huang M; Wang J Am J Cardiol; 2016 Sep; 118(6):888-894. PubMed ID: 27460667 [TBL] [Abstract][Full Text] [Related]
5. A rare phenotype of heterozygous Danon disease mimicking apical hypertrophic cardiomyopathy. Yu L; Wan K; Han Y; Chen Y Eur Heart J; 2018 Sep; 39(34):3263-3264. PubMed ID: 29240871 [No Abstract] [Full Text] [Related]
6. [Danon disease: a case report and literature overview]. Catović S; Otasević P Srp Arh Celok Lek; 2007; 135(3-4):197-200. PubMed ID: 17642461 [TBL] [Abstract][Full Text] [Related]
7. Clinical utility of genetic testing in the early diagnosis of Danon disease mimicking hypertrophic cardiomyopathy: a case report. Novelli V; Bisignani A; Pelargonio G; Primiano G; Narducci ML; Palmieri V; Tiziano FD; Zeppilli P; Servidei S; Crea F; Genuardi M BMC Cardiovasc Disord; 2020 Apr; 20(1):156. PubMed ID: 32248794 [TBL] [Abstract][Full Text] [Related]
8. A novel LAMP2 p.G93R mutation associated with mild Danon disease presenting with familial hypertrophic cardiomyopathy. Xu J; Wang L; Liu X; Dai Q Mol Genet Genomic Med; 2019 Oct; 7(10):e00941. PubMed ID: 31464081 [TBL] [Abstract][Full Text] [Related]
9. Generalized lysosome-associated membrane protein-2 defect explains multisystem clinical involvement and allows leukocyte diagnostic screening in Danon disease. Fanin M; Nascimbeni AC; Fulizio L; Spinazzi M; Melacini P; Angelini C Am J Pathol; 2006 Apr; 168(4):1309-20. PubMed ID: 16565504 [TBL] [Abstract][Full Text] [Related]
10. Danon disease as a cause of autophagic vacuolar myopathy. Yang Z; Vatta M Congenit Heart Dis; 2007; 2(6):404-9. PubMed ID: 18377432 [TBL] [Abstract][Full Text] [Related]
11. Paediatric hypertrophic cardiomyopathy secondary to Danon disease. Tang K; Wu J; Liu X; Wang S Cardiol Young; 2024 Jan; 34(1):201-204. PubMed ID: 37990583 [TBL] [Abstract][Full Text] [Related]
12. Morphologic and clinical aspects of Danon disease in a patient with a mutation c.137G > A in the LAMP-2 gene. Fidzianska A; Madej-Pilarczyk A; Walczak E; Kuch M Neuropediatrics; 2013 Oct; 44(5):276-80. PubMed ID: 23504560 [TBL] [Abstract][Full Text] [Related]
14. Danon disease presenting with early onset of hypertrophic cardiomyopathy and peripheral pigmentary retinal dystrophy in a female with a Meinert M; Englund E; Hedberg-Oldfors C; Oldfors A; Kornhall B; Lundin C; Wittström E Ophthalmic Genet; 2019 Jun; 40(3):227-236. PubMed ID: 31264915 [No Abstract] [Full Text] [Related]
15. Asymptomatic young man with Danon disease. Kim J; Parikh P; Mahboob M; Arrighi JA; Atalay MK; Rowin EJ; Maron MS Tex Heart Inst J; 2014 Jun; 41(3):332-4. PubMed ID: 24955057 [TBL] [Abstract][Full Text] [Related]
16. A new phenotype of severe dilated cardiomyopathy associated with a mutation in the LAMP2 gene previously known to cause hypertrophic cardiomyopathy in the context of Danon disease. Gourzi P; Pantou MP; Gkouziouta A; Kaklamanis L; Tsiapras D; Zygouri C; Constantoulakis P; Adamopoulos S; Degiannis D Eur J Med Genet; 2019 Jan; 62(1):77-80. PubMed ID: 29753918 [TBL] [Abstract][Full Text] [Related]
17. Molecular and histologic insights on early onset cardiomyopathy in Danon disease females. Fernández L; Casamayor Polo L; Bravo García-Morato M; Enguita Valls AB; Ruiz-Bravo E; Muñoz-Cabello P; Ibáñez K; Rodríguez-Laguna L; Martín-Arenas R; Ortega M; Palomares-Bralo M; Del Pozo Á; García-Guereta L; García-Miñaúr S; Lapunzina P; Vallespín E Clin Genet; 2021 Mar; 99(3):481-483. PubMed ID: 33226119 [No Abstract] [Full Text] [Related]
18. Arrhythmias and fasciculoventricular pathways in patients with Danon disease: A single center experience. Jhaveri S; Herber J; Zahka K; Boyle GJ; Saarel EV; Aziz PF J Cardiovasc Electrophysiol; 2019 Oct; 30(10):1932-1938. PubMed ID: 31240821 [TBL] [Abstract][Full Text] [Related]
19. A 13-year-old girl with proximal weakness and hypertrophic cardiomyopathy with Danon disease. Kim H; Cho A; Lim BC; Kim MJ; Kim KJ; Nishino I; Hwang YS; Chae JH Muscle Nerve; 2010 Jun; 41(6):879-82. PubMed ID: 20513107 [TBL] [Abstract][Full Text] [Related]
20. Malignant cardiac phenotypic expression of Danon disease (LAMP2 cardiomyopathy). Samad F; Jain R; Jan MF; Sulemanjee NZ; Menaria P; Kalvin L; Bush M; Jahangir A; Khandheria BK; Tajik AJ Int J Cardiol; 2017 Oct; 245():201-206. PubMed ID: 28874292 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]